These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Comparative analysis of pyrosequencing and QMC-PCR in conjunction with high resolution melting for KRAS/BRAF mutation detection. Ibrahem S; Seth R; O'Sullivan B; Fadhil W; Taniere P; Ilyas M Int J Exp Pathol; 2010 Dec; 91(6):500-5. PubMed ID: 21199003 [TBL] [Abstract][Full Text] [Related]
30. [High-throughput screening method of KRAS mutations at codons 12 and 13 in formalin-fixed paraffin-embedded tissue specimens of metastatic colorectal cancer]. Fukushima Y; Yanaka S; Murakami K; Abe Y; Koshizaka T; Hara H; Samejima C; Kishi Y; Kaneda M; Yoshino T Gan To Kagaku Ryoho; 2011 Nov; 38(11):1825-35. PubMed ID: 22083191 [TBL] [Abstract][Full Text] [Related]
31. Extended RAS and BRAF Mutation Analysis Using Next-Generation Sequencing. Sakai K; Tsurutani J; Yamanaka T; Yoneshige A; Ito A; Togashi Y; De Velasco MA; Terashima M; Fujita Y; Tomida S; Tamura T; Nakagawa K; Nishio K PLoS One; 2015; 10(5):e0121891. PubMed ID: 25954997 [TBL] [Abstract][Full Text] [Related]
32. KRas and BRaf mutational status analysis from formalin-fixed, paraffin-embedded tissues using multiplex polymerase chain reaction-based assay. Jakubauskas A; Griskevicius L Arch Pathol Lab Med; 2010 Apr; 134(4):620-4. PubMed ID: 20367313 [TBL] [Abstract][Full Text] [Related]
33. Development of a gLCR-based KRAS mutation detection approach and its comparison with other screening methods. Jenner S; Techel D Tumour Biol; 2015 Aug; 36(8):6361-8. PubMed ID: 25813150 [TBL] [Abstract][Full Text] [Related]
34. Optimization of routine KRAS mutation PCR-based testing procedure for rational individualized first-line-targeted therapy selection in metastatic colorectal cancer. Chretien AS; Harlé A; Meyer-Lefebvre M; Rouyer M; Husson M; Ramacci C; Harter V; Genin P; Leroux A; Merlin JL Cancer Med; 2013 Feb; 2(1):11-20. PubMed ID: 24133623 [TBL] [Abstract][Full Text] [Related]
35. Validation of targeted next-generation sequencing for RAS mutation detection in FFPE colorectal cancer tissues: comparison with Sanger sequencing and ARMS-Scorpion real-time PCR. Gao J; Wu H; Wang L; Zhang H; Duan H; Lu J; Liang Z BMJ Open; 2016 Jan; 6(1):e009532. PubMed ID: 26747035 [TBL] [Abstract][Full Text] [Related]
36. Detection of low-level DNA mutation by ARMS-blocker-Tm PCR. Qu S; Liu L; Gan S; Feng H; Zhao J; Zhao J; Liu Q; Gao S; Chen W; Wang M; Jiang Y; Huang J Clin Biochem; 2016 Feb; 49(3):287-91. PubMed ID: 26169242 [TBL] [Abstract][Full Text] [Related]
37. KRAS mutations in patients with colorectal cancer as detected by high-resolution melting analysis and direct sequencing. Akiyoshi K; Yamada Y; Honma Y; Iwasa S; Kato K; Hamaguchi T; Shimada Y; Taniguchi H; Furuta K Anticancer Res; 2013 May; 33(5):2129-34. PubMed ID: 23645765 [TBL] [Abstract][Full Text] [Related]
38. Cycleave polymerase chain reaction method is practically applicable for V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS)/V-raf murine sarcoma viral oncogene homolog B1 (BRAF) genotyping in colorectal cancer. Yokota T; Shibata N; Ura T; Takahari D; Shitara K; Muro K; Yatabe Y Transl Res; 2010 Aug; 156(2):98-105. PubMed ID: 20627194 [TBL] [Abstract][Full Text] [Related]
39. KRAS mutant allele-specific imbalance (MASI) assessment in routine samples of patients with metastatic colorectal cancer. Malapelle U; Sgariglia R; De Stefano A; Bellevicine C; Vigliar E; de Biase D; Sepe R; Pallante P; Carlomagno C; Tallini G; Troncone G J Clin Pathol; 2015 Apr; 68(4):265-9. PubMed ID: 25609577 [TBL] [Abstract][Full Text] [Related]
40. Comparison of COBAS 4800 KRAS, TaqMan PCR and high resolution melting PCR assays for the detection of KRAS somatic mutations in formalin-fixed paraffin embedded colorectal carcinomas. Harlé A; Busser B; Rouyer M; Harter V; Genin P; Leroux A; Merlin JL Virchows Arch; 2013 Mar; 462(3):329-35. PubMed ID: 23400679 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]